Zheng Xing Xing Ye Ri Bao·2025-10-15 08:37Core Insights - The biopharmaceutical sector experienced a rise of 1.78% on October 15, with Sai Sheng Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Company Performance - Sai Sheng Pharmaceutical (300485) closed at 12.28, with a gain of 9.16% and a trading volume of 369,300 shares [1] - Kanghua Biological (300841) closed at 77.71, up 6.02%, with a trading volume of 49,400 shares [1] - Kangchen Pharmaceutical (603590) closed at 49.11, increasing by 5.84%, with a trading volume of 40,700 shares [1] - San Sheng Guo Jian (688336) closed at 53.00, up 5.68%, with a trading volume of 56,800 shares [1] - Bai Pu Sai Si (301080) closed at 57.73, gaining 5.23%, with a trading volume of 28,000 shares [1] - Rongchang Biological (688331) closed at 96.05, up 5.20%, with a trading volume of 72,700 shares [1] - Shenzhou Cell (688520) closed at 55.03, increasing by 4.90%, with a trading volume of 42,700 shares [1] - Kang Le Wei Shi (920575) closed at 12.94, up 4.61%, with a trading volume of 53,900 shares [1] - Tonghua Dongbao (600867) closed at 8.96, gaining 4.55%, with a trading volume of 543,800 shares [1] - Olin Biological (61688919) closed at 24.96, up 4.22%, with a trading volume of 65,800 shares [1] Market Capital Flow - The biopharmaceutical sector saw a net inflow of 331 million yuan from institutional investors, while retail investors experienced a net outflow of 234 million yuan [2] - The main funds showed a net inflow in several companies, including Changchun High-tech (000661) with 66.94 million yuan and Tonghua Dongbao (600867) with 62.56 million yuan [3] - Retail investors showed significant outflows in companies like Sai Sheng Pharmaceutical (300485) with 50.24 million yuan and Rongchang Biological (688331) with 38.34 million yuan [3]